09.10.2013 10:42:30

Press Release: Nestle: Nestlé scientists help to identify biomarkers for obesity-related health problems

-1 of 2- 09 Oct 2013 08:11:00 UTC  *DJ Nestle: Nestlé scientists help to identify biomarkers for obesity-related health problems

   (MORE TO FOLLOW) Dow Jones Newswires

   October 09, 2013 04:11 ET (08:11 GMT)- - 04 11 AM EDT 10-09-13

-2 of 2- 09 Oct 2013 08:11:00 UTC  Press Release: Nestle: Nestlé scientists help to identify biomarkers for obesity-related health problems

Nestlé S.A. / Nestlé scientists help to identify biomarkers for obesity-related health problems . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.

People with visceral obesity share a unique set of biomarkers that could one day be used to identify individuals more likely to be at risk of developing obesity-related health problems, a new study suggests.

Scientists from the Nestlé Research Center http://www.research.nestle.com/newscenter/news/nestl%c3%a9researcherssearchfornovelingredientstoimproveglucosecontrolfortype2diabetes in Switzerland studied a group of women with visceral obesity - where excess fat is concentrated around the internal organs - and discovered they had a distinct 'metabolic signature' of lipids and amino acids in common, as well as specific changes in gut microbial activities.

The findings, published in the journal http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0073445 PLOS ONE, are part of an ongoing scientific collaboration http://www.research.nestle.com/newscenter/news/nestl%C3%A9scienceandresearchandgecollaboratetoexplorenewfrontiersindiagnosticsforhealthandnutrition between Nestlé and General Electric http://ge.geglobalresearch.com/ to find efficient and inexpensive methods of screening and monitoring body composition in individuals.

Higher risk

"People who have visceral obesity are recognised as being at higher risk of developing certain related illnesses," said François-Pierre Martin, the Nestlé scientist who led the study.

"Finding minimally-invasive, fast and reliable biomarkers to screen people for visceral obesity could help to monitor the effectiveness of different therapies," he continued.

"In the future it could be an efficient and accessible way of helping to address the burden of obesity-related problems such as insulin resistance, Type 2 diabetes and cardiovascular disease."

Imaging techniques

In the study, scientists monitored 40 obese but otherwise healthy women over a two-week period at the out-patient obesity clinic of the University Hospital of Lausanne http://www.chuv.ch/ , Switzerland.

They measured the women's body composition and distribution of fat tissue with modern imaging techniques such as dual energy X-ray absorptiometry (DXA) and computed tomography (CT), using technology provided by General Electric.

They also took blood and urine samples at regular intervals to monitor individuals' metabolism.

Wider research

The study is part of a much wider programme of research conducted by Nestlé into human metabolism as well as obesity and its related health problems.

Scientific work carried out by the company in these areas has included studies examining the effects of various protein sources on energy metabolism, satiety and glucose control http://www.nestle.com/media/newsandfeatures/are-all-proteins-alike , the complex signals sent by the gut to the brain http://www.nestle.com/media/newsandfeatures/the-brain-in-your-gut , how to improve glucose control for type two diabetes http://www.research.nestle.com/newscenter/news/nestl%c3%a9researcherssearchfornovelingredientstoimproveglucosecontrolfortype2diabetes and the effect of chewing on satiety http://www.nestle.com/media/newsandfeatures/nestle-satiety-study .

Related information:

Nestlé Research Center http://www.research.nestle.com/newscenter/news/nestl%c3%a9researcherssearchfornovelingredientstoimproveglucosecontrolfortype2diabetes

General Electric Research

http://ge.geglobalresearch.com/

University Hospital of Lausanne

http://www.chuv.ch/

Link to published study: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0073445

Read more stories about Nestlé research:

Nestlé research identifies metabolic signature for long life

http://www.nestle.com/Media/NewsAndFeatures/NRC-longevity-study

Nestlé expands research and development facilities in Singapore

http://www.nestle.com/Media/NewsAndFeatures/Nestle-expands-research-and-development-facilities-in-Singapore

Nestlé opens most advanced laboratories in industry to study harmful pathogens in food

http://www.nestle.com/Media/NewsAndFeatures/NRC-food-safety-labs

Media enquiries

Tel: +41 21 924 2200

Email: Nestlé Corporate Media Relations mailto:mediarelations@nestle.com

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the

information contained therein.

Source: Nestlé S.A. via Thomson Reuters ONE

HUG#1734500

--- End of Message ---

Nestlé S.A.

Avenue Nestlé 55 Vevey Switzerland

WKN: 887208;ISIN: CH0038863350;

http://www.nestle.com (END) Dow Jones Newswires

   October 09, 2013 04:11 ET (08:11 GMT)- - 04 11 AM EDT 10-09-13

Analysen zu Nestle S.A. (spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Nestle S.A. (spons. ADRs) 79,40 -1,00% Nestle S.A. (spons. ADRs)